DABUR · Consumer Defensive · Household & Personal Products
Composite scorecard: 46/100 — Quality 68 · Valuation 49 · Growth 17 · Momentum 34
| Share price | ₹426.50 |
| Market cap | ₹91,966 Cr |
| P/E ratio | 50.0 |
| P/B ratio | 8.4 |
| ROE | 16.4% |
| ROCE | 20.2% |
| Dividend yield | 1.54% |
| Book value | ₹61.75 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹13,193 Cr | ₹1,869 Cr | 19.0% |
| 2025 | ₹12,563 Cr | ₹1,740 Cr | 18.0% |
| 2024 | ₹12,404 Cr | ₹1,811 Cr | 19.0% |
| 2023 | ₹11,530 Cr | ₹1,701 Cr | 19.0% |
| 2022 | ₹10,889 Cr | ₹1,742 Cr | 21.0% |
Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola and Pudin Hara; cough and cold products under the Honitus brands name; rejuvenators under the Shilajit brand name; health juices; nutraceuticals under the Siens brand name; and baby care products under the Dabur Lal Tail, Janma Ghunti, Gripe Water, and Dabur Baby brand nam